BioDelivery Sciences logo
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
September 25, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018
September 13, 2018 07:30 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 21, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
August 16, 2018 08:30 ET | SPR Therapeutics, Inc.
SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...
BioDelivery Sciences logo
BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA®
August 15, 2018 09:26 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
BioDelivery Sciences logo
BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results
August 09, 2018 16:05 ET | BioDelivery Sciences International, Inc.
BELBUCA® Continues Its Accelerated Record Prescription Growth of 80% YOY and 31% Versus the Prior Quarter Company Provides Overview of New Plan to Capitalize on Long Term Net Revenue Potential of...
BioDelivery Sciences logo
BioDelivery Sciences Appoints Thomas Smith, MD as Chief Medical Officer Further Expanding Company’s Expertise in Field of Pain Management
July 30, 2018 07:55 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., July 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial based specialty pharmaceutical company focused on patients living with...
CFN LOGO.png
Tree of Knowledge Goes Public on the CSE Backed by Strong Management Team and Advisory Board -- CFN Media
July 18, 2018 09:00 ET | CFN Media
SEATTLE, July 18, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced...
54aafc79868f4b00075cb3a1_logo.jpg
Canbiola, Inc. (OTC PINK: CANB) Revenue and Shareholder 2nd Quarter Update
July 09, 2018 09:00 ET | Canbiola, Inc.
HICKSVILLE, NY. , July 09, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB) Canbiola is pleased to update shareholders on our progress for the first half of 2018. REVENUES: We expect...
PremierBiomedical-Logo-FINAL.jpg
Uptick Newswire Welcomes William Hartman, CEO of Premier Biomedical, Inc. Back on to the “Stock Day” Podcast
June 04, 2018 08:00 ET | Premier Biomedical, Inc.
PHOENIX, June 04, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical, Inc. (OTC Pink:BIEI) (“the Company”) was recently interviewed by Marcus Heatherly on Uptick Newswire’s “Stock...